OSHA Takes on Repetitive Stress Injuries

 

This Week’s Headlines from Libertarian
Sites
Of
Handguns and Talking Vaginas
by Wendy McElroy (The American
Partisan)
JAMming
a Prescription for Gun Grabs
by Stephen Milloy (CATO Institute)
The Best
Energy Policy Is No Energy Policy
by Jerry Taylor (CATO
Institute)
Immigration,
Moochers, and the Welfare State
by Andrew Lewis (Capitalism
Magazine)
How
America Barely Escaped The “McCain Phenomenon: John McCain’s
Statist Vision for America
by J. Patrick Mullins (Capitalism
Magazine)
Bad
Ideas, Not Guns, Kill People
by Dr. Michael J. Hurd (Capitalism
Magazine)
Beware
of a Stock Market that Trades Above Average
by Andrew West
(Capitalism Magazine)
The
American KGB: The Department of Justice’s Antitrust Department
by Richard M. Salsman (Capitalism Magazine)
Havana
Horror
by Glen Lamont (Free Radical)
Embracing
Ellsworth
by James M. Jowdy (Free Radical)
The
Ninth
by David C. Adams (Free Radical)
Cashing
In on the Values of American Education: Reflections on the Anniversary
of Littleton
by James J. Campbell (Free Radical)
Seatbelt,
Señor?
by David Bertelsen (Free Radical)
Credo by Deborah Coddington (Free Radical)
For
the Sake of Consumers, Allow AT&T/MediaOne Merger to Proceed
at Once
by Joseph L. Bast (Heartland Institute)
AOL-Time
Warner Merger Spells End of Forced Access Campaign
by Dave
Kopel (Heartland Institute)
Congress’s
Role In Improving Juvenile Delinquency Data
by Patrick F.
Fagan (Heritage Foundation)
The
President’s Flawed Plan To Aid Colombia
by Stephen Johnson
(Heritage Foundation)
Are
we Entering a Recession?
by Clifford F. Thies (Mises Institute)
The
Income Inequality Hoax
by William Anderson (Mises Institute)
PC
Left & Right
by Tibor R. Machan (Laissez-Faire City Times)
Repairman
Jack: an interview with F. Paul Wilson
by Russell Madden
(Laissez-Faire City Times)
Ron
Paul on Politics and Freedom: an interview
by Alberto Mingardi
and Carlo Stagnaro (Laissez-Faire City Times)
In
Praise of Chaos
by J. Orlin Grabbe (Laissez-Faire City Times)
Avoiding
the Issue Ads
by Brian Doherty (Reason)
Selective
Liability
by Walter Olson (Law News Network)
The
Secrets of the Clinton Spectacle: A five-step program for surviving
endless scandal
by Charles Paul Freund (Reason)
 

   

The Occupational Safety Health
Association recently did what it does best – proposing regulations that
won’t likely do much to improve the safety of American workers but could
dramatically increase costs for businesses.

The latest round of OSHA wastefulness
is aimed at preventing repetitive stress injuries. These are musculoskeletal
disorders that account for one third of all occupational injuries. The
new regulations will dictate ergonomic standards for businesses in an
effort to reduce the risk of RSI injuries. Unfortunately there is very
little scientific evidence available yet to indicate how to reduce the
risk of RSI’s, and such information is unlikely to be available anytime
soon.

The main problem in studying
RSIs being that they have numerous causes. As Jennifer Krause, director
of employment policy for the National Association of Manufacturers summed
it up, “There is lack of consensus in the scientific and medical communities
on the causes of MSDs (musculoskeletal disorders). Certainly not enough
to justify a rule of this magnitude.”

In fact although ergonomics
does in fact seem to play a role in some RSI injuries, deciding how much
of a role ergonomics plays or how to ameliorate RSIs by modifying ergonomics
is at best little more than guesswork.

As Russell E. Windsor, an orthopedic
surgeon and expert in joint replacement surgery, told CNN, “It is difficult
to apply critical, scientific methods to determine that a particular action
done repetitively over a number of hours will result in injury.” Factors
such as work schedules, the pace of work, time pressures, and other factors
can all contribute to musculoskeletal disorders, and deciding how to assign
the proportional risk among different factors is all but impossible.

OSHA counters that there are
quite a few success stories where employers reduced workplace injuries
by making ergonomic changes, but this highlights exactly why OSHA oversight
is problematic. But this undercuts OSHA’s very reasoning for new regulations.
Given the difficulty in finding an optimal ergonomic work environment,
the last thing businesses need are inflexible rules that might require
changes costing billions of dollars (even OSHA’s low-ball figure estimates
$4.6 billion annually to comply with its regulations) while producing
results that are unpredictable.

OSHA’s reflexive regulations
seem little more than a common Washington reaction — anytime any problem
is discovered, it must be regulated. Sometimes, though, such regulation
merely adds expensive requirements while producing minimal results. Such
is likely to be the case with OSHA’s ergonomic rules.

Virginia hunting amendment to go to voters in November

The Virginia General Assembly
recently a proved a state constitutional amendment that would guarantee
Virginians the right to hunt and fish in that state. The amendment passed
the Virginia state Senate 24 to 16. It must still be approved by voters
in the November election.

The amendment specifically
alters the state constitution to read that “the people have a right to
hunt, fish, and harvest game, subject to such regulations as the General
Assembly may prescribe by general law.”

The bill was opposed by groups
and individuals afraid it might weaken local gun control statutes in Virginia
cities as well as localized bans on hunting within some city limits. “Do
you really want hunting in your incorporated cities and towns?” asked
Republican Sen. William C. Mims during the debate on the measure.

Whether the amendment would
override local gun control or hunting regulations is debatable since most
such restrictions are on state-owned land and the result of strictures
passed by the state legislature, which would clearly remain constitutional
under the new amendment.

Before the vote the Humane
Society of the United States issued a press release opposing the amendment
and is likely to campaign against it in November. According to an HSUS
press release,

House Joint Resolution 124 (HJR 124) is a radical proposition
that amends the state constitution so that it designates hunting, fishing,
and the harvesting of game as constitutional rights. . . . Virginia citizens,
contact your state senator today and urge him or her to vote against HJR
124. Point out that Virginia’s constitution does not even guarantee citizens
the right to basic needs such as food, shelter or health care, so make
this effort to provide constitutional protection to recreational pursuits
is extremely inappropriate and offensive.

But of course, all the amendment
does at the end of the day is reaffirm the legitimacy of property rights
in animals-a principle that, despite all of it claims that it is not an
animal rights organization, HSUS clearly seems to stand diametrically
opposed.

References:

Virginia
assembly passes right-to-hunt amendment
. Washington Post, March 1,
2000.

Virginia: Don’t make
hunting and trapping constitutional rights
. Press release, Human Society
of the United States, February 24, 2000.

Appeals court upholds Oprah Winfrey's victory over cattlemen

    The 5th U.S. Circuit Court
of Appeals recently turned down an appeal by a Texas cattleman of Oprah
Winfrey’s victory in the so-called “veggie libel” trial a couples years
ago.

    In that trial, the cattlemen
sued Winfrey over her April 16, 1996 show which featured animal rights
activist Howard Lyman discussing Mad Cow disease. Lyman went on with his
usual histrionics about Mad Cow disease, with flourishes claiming that
Mad Cow could possibly kill millions of people in the United States, prompting
Winfrey to say she’d never eat another hamburger again.

    Beef sales, and prices, dropped
dramatically in the wake of the show (it is frightening to think that
so many Americans get dietary advice from a day-time talk show) , and
the cattlemen sued in Texas under a law that makes disparaging a food
product a tort. Unfortunately for the cattlemen, the trial judge ruled
that the law did not apply to meat (it had originally been written to
cover fruits and vegetables specifically) and the cattlemen had to sue
Winfrey under the much stricter libel laws.

    The appeal, initiated by Paul
Engler who has vowed to appeal the Winfrey verdict as far as possible,
argued that the trial judge erred in not allowing the suit to continue
under the veggie libel provision.

    Hopefully this will spell the
end of this ridiculous chapter-the lawsuit’s main affect was to make the
cattlemen look like a bunch of whiners. As the Appeals Court put it,

Stripped to its essentials, the cattlemen’s complaint is that
the ‘Dangerous Food’ show did not present the mad cow issue in the light
most favorable to United States beef. This argument cannot stand.

    Lyman might be a nut and Winfrey
a fool, but even nuts and fools are protected by the First Amendment (and
thankfully so — all Engler’s vindictive legal tactics have done is further
legitimize Lyman’s bizarre views).

Reference:

Oprah’s
win over cattlemen upheld
. Janet McConnaughey, Associated Press, February
9, 2000.

FDA vs. Women’s Health, Again

Feminists in the United States
waged a decade-long battle against right wing activists to bring an important
medical technology to the United States only to experience years of foot
dragging from the Clinton administration which recently announced it still
won’t allow women access to a drug that has been available in Europe for
12 years.

The drug, of course, is RU-486
and induces an abortion 95.5 percent of the time when taken within the
first 49 days of pregnancy. Originally developed by Hoechst AG, the drug
first went on sale in France in 1988.

Unfortunately anti-abortion
activists actively campaigned to keep the drug from being available in
the United States. Promising to retaliate against Hoechst AG if the drug
were sold in the United States, the drug company refused to allow Roussel
Uclaf — which held RU-486’s marketing rights for the United States —
to market the drug here.

The anti-abortion groups were
aided by Congress and the Bush administration. In 1989 the U.S. Food and
Drug Administration banned the import of RU-486 for personal use. U.S.
Customs seized a prescription of RU-486 from an American citizen brought
to the United States after a trip to Europe and the Supreme Court refused
to hear the pregnant woman’s appeal of the seizure, allowing the FDA ban
to stand.

But feminists thought that
would all change with the election of Bill Clinton in 1992. In an effort
to court feminist voters, candidate Clinton pledged his support for bringing
RU-486 to this country and after the election the FDA announced that it
could review and approve RU-486 in as little as six months. FDA Commissioner
David Kessler wrote to Roussel Uclaf and encouraged the company to submit
the drug for approval.

Unfortunately Hoechst AG and
Roussel Uclaf still were resistant to selling the drug in the United States,
but agreed to transfer the marketing rights to the nonprofit Population
Council. Finally, on May 16, 1994 the Population Council was granted the
U.S. patent rights to RU-486 and clinical trials began in October 1994.
And almost six years later the drug is still not available in the
United States (so much for that six month speedy approval the Clinton
FDA promised.)

All of the studies conducted
so far indicate the drug is safe and effective, yet the FDA still refuses
to grant it final approval. Just last week, the FDA announced that it
still is not ready to approve the drug, saying that it had concerns about
the manufacturing and labeling of the drug, which is pretty much the same
thing the FDA said in a 1996 letter.

Planned Parenthood spokeswoman
hit the nail on the head when she said, “We think it’s appalling that
for 10 years the world’s most industrialized nation has not had access
to this drug that would benefit women.”

This is a classic example of
the idiocy of the FDA. Although in the 1950s or 1960s, U.S. drug approval
processes might have been said to be superior to Europe’s, today the techniques
for distinguishing between safe and unsafe medications are well known
and practiced by all Western industrial nations. A much better policy
would be to allow any drug approved for sale in Europe to be sold in the
United States with a warning that the drug has been reviewed by European
regulatory agencies but not the U.S. FDA.

Why not let women choose for
themselves what to do with their bodies? Or are we to assume that the
same woman able to decide whether or not to abort a fetus is simply incapable
of making a decision about whether or not to take a drug that has been
approved an in use in Europe for more than a decade?

References:

French
abortion pill falls short of FDA requirements
. Fox News, February
21, 2000.

The Fight To
Make RU-486 Available To U.S. Women
. From The Feminist Majority Foundation.

FDA vs. Women’s Health Again

Feminists in the United States
waged a decade-long battle against right wing activists to bring an important
medical technology to the United States only to experience years of foot
dragging from the Clinton administration which recently announced it still
won’t allow women access to a drug that has been available in Europe for
12 years.

The drug, of course, is RU-486
and induces an abortion 95.5 percent of the time when taken within the
first 49 days of pregnancy. Originally developed by Hoechst AG, the drug
first went on sale in France in 1988.

Unfortunately anti-abortion
activists actively campaigned to keep the drug from being available in
the United States. Promising to retaliate against Hoechst AG if the drug
were sold in the United States, the drug company refused to allow Roussel
Uclaf — which held RU-486’s marketing rights for the United States —
to market the drug here.

The anti-abortion groups were
aided by Congress and the Bush administration. In 1989 the U.S. Food and
Drug Administration banned the import of RU-486 for personal use. U.S.
Customs seized a prescription of RU-486 from an American citizen brought
to the United States after a trip to Europe and the Supreme Court refused
to hear the pregnant woman’s appeal of the seizure, allowing the FDA ban
to stand.

But feminists thought that
would all change with the election of Bill Clinton in 1992. In an effort
to court feminist voters, candidate Clinton pledged his support for bringing
RU-486 to this country and after the election the FDA announced that it
could review and approve RU-486 in as little as six months. FDA Commissioner
David Kessler wrote to Roussel Uclaf and encouraged the company to submit
the drug for approval.

Unfortunately Hoechst AG and
Roussel Uclaf still were resistant to selling the drug in the United States,
but agreed to transfer the marketing rights to the nonprofit Population
Council. Finally, on May 16, 1994 the Population Council was granted the
U.S. patent rights to RU-486 and clinical trials began in October 1994.
And almost six years later the drug is still not available in the
United States (so much for that six month speedy approval the Clinton
FDA promised.)

All of the studies conducted
so far indicate the drug is safe and effective, yet the FDA still refuses
to grant it final approval. Just last week, the FDA announced that it
still is not ready to approve the drug, saying that it had concerns about
the manufacturing and labeling of the drug, which is pretty much the same
thing the FDA said in a 1996 letter.

Planned Parenthood spokeswoman
hit the nail on the head when she said, “We think it’s appalling that
for 10 years the world’s most industrialized nation has not had access
to this drug that would benefit women.”

This is a classic example of
the idiocy of the FDA. Although in the 1950s or 1960s, U.S. drug approval
processes might have been said to be superior to Europe’s, today the techniques
for distinguishing between safe and unsafe medications are well known
and practiced by all Western industrial nations. A much better policy
would be to allow any drug approved for sale in Europe to be sold in the
United States with a warning that the drug has been reviewed by European
regulatory agencies but not the U.S. FDA.

Why not let women choose for
themselves what to do with their bodies? Or are we to assume that the
same woman able to decide whether or not to abort a fetus is simply incapable
of making a decision about whether or not to take a drug that has been
approved an in use in Europe for more than a decade?

French
abortion pill falls short of FDA requirements
. Fox News, February
21, 2000.

The Fight To
Make RU-486 Available To U.S. Women
. From The Feminist Majority Foundation.

Animal rights activist accused of suborning perjury, case thrown out

    Wisconsin animal rights activist
Cindy Schultz did not appreciate being mentioned as a possible suspect
in a high profile dognapping case in Milwaukee and sued the Milwaukee
Journal Sentinel, local radio host Charles Sykes, and his employer the
Journal Broadcast Group.

    Unfortunately for her, a circuit
judge hearing the case summarily dismissed all charges after Schultz apparently
committed perjury and attempted to suborn the perjury of another witness.

    Schultz heads an animal rights
group called the Animal Lobby and is a political operative who worked
on the campaigns of a variety of state and national political candidates.

    Schultz was initially charged
in the theft of two dogs, but the charges were later dismissed; Schultz
denies she was involved in the theft. Before the libel trial a former
friend of Schultz’s, Clary Engel, came forward to claim that Schultz had
asked him to lie about where she was on the day the dogs were stolen and
that Schultz had once asked him to steal the dogs.

    Schultz denied that she asked
Engel to lie, but unfortunately for her Engel still had copies of typewritten
“scripts” that Schultz had written illustrating how Engel should answer
questions at trial. Schultz lamely argued that although she had indeed
typed up scripts for Schultz, she wasn’t suborning perjury because everything
in the scripts was true. This despite the fact that one of the typed scripts
instructed Engel to testify that he had never discussed his testimony
with Schultz.

    In dismissing the civil suit,
Milwaukee County Circuit Judge Francis Wasielewski said Schultz had tried
to commit a “fraud on the court.”

[Schultz] . . . gave this court the impression of evasiveness
on several occasions. . . . Sometimes she avoided questions posed by answering
other questions. . . . She seemed to duck questions with feigned confusion.
Overall, she didn’t give this court the impression of being forthcoming
in testifying and of being someone who wanted to aid in a search for the
truth.

    Schultz’s lawsuit, aimed she
said at recovering damages for her ruined reputation, could end up costing
her even more. Because of the alleged perjury, the defense attorneys are
now planning a motion to force Schultz to pay all of the defendant’s legal
fees, which a defense lawyer described as being “substantial.”

Reference:

Animal
rights activist’s suit tossed out
. Jessica McBride, Milwaukee Journal
Sentinel, January 21, 2000.